Published in J Virol on September 01, 1977
A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol (1985) 5.78
Genomes of murine leukemia viruses isolated from wild mice. J Virol (1981) 4.24
Relationship of retrovirus polyprotein cleavages to virion maturation studied with temperature-sensitive murine leukemia virus mutants. J Virol (1978) 4.06
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol (1994) 3.59
Nucleotide sequence of the Akv env gene. J Virol (1982) 3.53
Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J Virol (1983) 3.41
Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci U S A (1981) 3.13
Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene. Proc Natl Acad Sci U S A (1980) 2.90
Nucleotide sequence of the 3' end of MCF 247 murine leukemia virus. J Virol (1983) 2.87
Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J Virol (1993) 2.80
Structure of the murine leukemia virus envelope glycoprotein precursor. J Virol (1979) 2.51
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Cloning and characterization of an envelope-specific probe from xenotropic murine leukemia proviral DNA. J Virol (1982) 2.09
Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J Virol (1994) 1.97
Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J Virol (1979) 1.90
Glycoprotein encoded by the Friend spleen focus-forming virus. J Virol (1979) 1.89
A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci U S A (1992) 1.83
Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus. J Virol (1981) 1.61
Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus. J Virol (1979) 1.61
Characterization of proviruses cloned from mink cell focus-forming virus-infected cellular DNA. J Virol (1982) 1.60
Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses. J Virol (1980) 1.46
Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med (1978) 1.42
Detection and cloning of murine leukemia virus-related sequences from African green monkey liver DNA. J Virol (1981) 1.38
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. Proc Natl Acad Sci U S A (1980) 1.36
Nucleotide sequence of the env-specific segment of NFS-Th-1 xenotropic murine leukemia virus. J Virol (1983) 1.34
Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J Virol (1999) 1.33
Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin. J Virol (1983) 1.25
Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E. J Exp Med (1983) 1.22
Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein. Proc Natl Acad Sci U S A (1978) 1.17
Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces. Proc Natl Acad Sci U S A (1978) 1.16
Polyprotein precursors to mouse mammary tumor virus proteins. J Virol (1979) 1.06
The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions. J Virol (1999) 1.03
Envelope polypeptides of Friend leukemia virus: purification and structural analysis. J Virol (1980) 1.03
Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations. J Virol (1998) 0.99
Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins. J Virol (1982) 0.97
Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J Virol (1996) 0.87
Structural studies on Rauscher murine leukemia virus: isolation and characterization of viral envelopes. J Virol (1978) 0.86
Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: identification of an N-terminal 45,000-dalton cleavage product. J Virol (1983) 0.85
An increase in disease latency is associated with a host-dependent selection for recombinant murine leukemia viruses with substitutions in the p15E (TM) gene. J Virol (1993) 0.84
Characterization of intracellular precursor polyproteins of Moloney murine leukemia virus. J Virol (1979) 0.82
Detection of phosphorylated forms of Moloney murine leukemia virus major capsid protein p30 by immunoprecipitation and two-dimensional gel electrophoresis. J Virol (1988) 0.81
Alterations in chromatin of cells infected with RNA tumor viruses. Nucleic Acids Res (1978) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem (1975) 56.72
Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J Mol Biol (1975) 6.84
Tumor viruses: 1974. Cold Spring Harb Symp Quant Biol (1975) 4.44
Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology (1977) 4.06
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
Glycoprotein components of avian and murine RNA tumor viruses. Virology (1970) 3.92
Effect of pactamycin on synthesis of poliovirus proteins: a method for genetic mapping. J Virol (1971) 3.67
Biosynthesis of Rauscher leukemia viral proteins. Cell (1975) 3.57
Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides. Virology (1976) 3.20
"gag" polyprotein precursors of Rauscher murine leukemia virus. Virology (1977) 2.95
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Determination of the gene sequence of poliovirus with pactamycin. Proc Natl Acad Sci U S A (1971) 2.80
High molecular weight precursor polypeptides to structural proteins of Rauscher murine leukemia virus. J Mol Biol (1976) 2.72
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E). J Virol (1975) 2.72
Resolution of simian virus 40 proteins in whole cell extracts by two-dimensional electrophoresis: heterogeneity of the major capsid protein. Cell (1976) 2.37
Structural proteins of ribonucleic acid tumor viruses. Purification of envelope, core, and internal components. J Biol Chem (1976) 2.31
Gene order of encephalomyocarditis virus as determined by studies with pactamycin. J Virol (1972) 2.26
A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71. Proc Natl Acad Sci U S A (1976) 2.22
Separation of two polypeptide chains from the hemagglutinin subunit of influenza virus. Virology (1971) 2.07
Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences. Virology (1975) 1.91
Purification of large amounts of murine ribonucleic acid tumor viruses produced in roller bottle cultures. Appl Microbiol (1972) 1.83
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol (1976) 1.69
Comparative studies on the structural phosphoproteins of mammalian type C viruses. J Virol (1975) 1.66
Structural proteins of Rauscher leukemia virus and Harvey sarcoma virus. Virology (1972) 1.57
Analysis of the envelope of Rauscher murine oncornavirus: in vitro labeling of glycopeptides. J Virol (1976) 1.03
Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology (1977) 4.06
Biosynthesis of Rauscher leukemia viral proteins. Cell (1975) 3.57
Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides. Virology (1976) 3.20
"gag" polyprotein precursors of Rauscher murine leukemia virus. Virology (1977) 2.95
A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71. Proc Natl Acad Sci U S A (1976) 2.22
P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc Natl Acad Sci U S A (1983) 1.95
Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences. Virology (1975) 1.91
Purification of large amounts of murine ribonucleic acid tumor viruses produced in roller bottle cultures. Appl Microbiol (1972) 1.83
Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA. Cell (1978) 1.71
Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol (1976) 1.69
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos. Virology (1985) 1.67
The cell-free translation of Rauscher leukemia virus RNA into high molecular weight polypeptides. Biochim Biophys Acta (1975) 1.65
Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. J Virol (1992) 1.64
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene (2009) 1.64
Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene (2001) 1.63
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Leukemia (2002) 1.62
Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus. J Virol (1981) 1.61
Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus. J Virol (1979) 1.61
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. J Virol (1993) 1.49
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. J Clin Microbiol (1987) 1.49
Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci U S A (1985) 1.47
Foot-and-mouth disease virus-induced ribonucleic acid polymerase in baby hamster kidney cells. Virology (1967) 1.46
The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid. Proc Natl Acad Sci U S A (1969) 1.45
A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus. Cell (1981) 1.43
Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J Virol (1979) 1.40
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Cell (1990) 1.35
Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood (1994) 1.23
Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. J Virol (1993) 1.22
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism. Leukemia (2008) 1.21
Ribosomes from Rauscher leukemia virus-infected cells and their response to Rauscher viral RNA and polyuridylic acid. Biochim Biophys Acta (1973) 1.19
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia. Blood (1987) 1.18
Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int (1995) 1.18
Biosynthesis of reverse transcriptase from Rauscher murine leukemia virus by synthesis and cleavage of a gag-pol read-through viral precursor polyprotein. Proc Natl Acad Sci U S A (1978) 1.17
Further characterization of the P85gag-mos -associated protein kinase activity. Virology (1984) 1.17
S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. J Virol (1984) 1.16
Structural components of a virus of the California encephalitis complex: LaCrosse virus. Virology (1973) 1.14
Inhibition of cell-free foot-and-mouth disease virus-ribonucleic acid synthesis by antibody. Virology (1967) 1.12
Processing of the env gene products of Moloney murine leukaemia virus. J Gen Virol (1982) 1.11
Electron microscopic analysis of ts1 10 Moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions. J Mol Biol (1982) 1.10
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway. J Biol Chem (1999) 1.08
Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos. J Virol (1985) 1.07
Detergent-solubilized RNA polymerase from cells infected with foot-and-mouth disease virus. Science (1967) 1.07
Cytoskeleton-associated Pr65gag and retrovirus assembly. Virology (1983) 1.06
p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J Virol (1986) 1.06
Polyprotein precursors to mouse mammary tumor virus proteins. J Virol (1979) 1.06
Sequence of events in the transformation process in cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 1.05
Cytoskeleton-associated Pr65gag and assembly of retrovirus temperature-sensitive mutants in chronically infected cells. Virology (1984) 1.05
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells. J Virol (1985) 1.05
Comparative tryptic peptide analysis of candidate P85gag-mos of ts110 Moloney murine sarcoma virus and P38-P23 mos gene-related proteins of wild-type virus. Virology (1982) 1.05
BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene (1993) 1.04
Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product. J Gen Virol (1985) 1.03
BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model. Oncogene (2001) 1.02
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Clin Cancer Res (1998) 1.02
Studies on foot-and-mouth disease virus ribonucleic acid synthesis. Virology (1966) 1.01
C-type virus particles produced by normal mouse spleen-thymus cultures. Virology (1972) 1.00
P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Oncogene (1990) 0.99
Inhibition of ribonucleic acid methylation in the foot-and-mouth disease virus-infected host cell. Biochem Biophys Res Commun (1967) 0.99
Identification of the protein product of the c-mos proto-oncogene in mouse testes. Oncogene (1988) 0.98
Site of foot-and-mouth disease virus-ribonucleic acid synthesis and some properties of its double-stranded ribonucleic acid. Biochim Biophys Acta (1968) 0.98
P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation. Cancer Res (1996) 0.98
Characterization of virus-specified proteins present in NRK cells infected with a temperature-sensitive transformation mutant of Moloney murine sarcoma virus. Cold Spring Harb Symp Quant Biol (1980) 0.97
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood (1996) 0.96
In vitro products of a membrane-free foot-and-mouth disease virus ribonucleic acid polymerase. Virology (1969) 0.96
Characterization of MEK1 phosphorylation by the v-Mos protein. Oncogene (1995) 0.95
The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity. Virology (1988) 0.95
Changes in protein and nucleic acid metabolism in baby hamster kidney cells infected with foot-and-mouth disease virus. Arch Gesamte Virusforsch (1968) 0.95
RNA polymerase complexes from mengovirus infected cells. Arch Gesamte Virusforsch (1972) 0.95
Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Virology (1992) 0.94
Inhibition of Bcr serine kinase by tyrosine phosphorylation. Mol Cell Biol (1996) 0.94
Gag-mos Polyproteins encoded by variants of the Moloney strain of mouse sarcoma virus. Virology (1983) 0.94
Moloney murine sarcoma virus encoded p37mos expressed in yeast has protein kinase activity. Virology (1986) 0.94
Tryptic peptide analyses of polypeptides generated by premature termination of cell-free protein synthesis allow a determination of the Rauscher leukemia virus gag gene order. J Virol (1978) 0.94
The translation products of Moloney murine sarcoma virus-124 RNA. Virology (1980) 0.93